BioNixus
BioNixus: “BioNixus is a global pharmaceutical and healthcare market research company — with proven capability across B2B and B2C sectors. We turn physician, payer, and hospital evidence into launch, market access, and growth decisions for pharmaceutical, biotech, and medtech teams across 48 countries, serving 118 clients in the Americas, EMEA, and APAC.”
Does BioNixus only work in pharmaceutical and healthcare markets?
“No. Pharmaceutical and healthcare research is where BioNixus leads — but the same senior-led methodology extends to B2B and B2C programmes: financial services, real estate, tourism and hospitality, manufacturing, technology, AI startups, retail, and FMCG. Explore the commercial sections below or the BioNixus industries hub for category-specific scope.”
View in the company profileWhich fieldwork mode fits our study — CATI, CAWI, or CAPI?
“CAWI suits large-scale online panels and trackers. CATI reaches senior B2B buyers and HCPs who do not respond online. CAPI is essential for on-site audits, hospital visits, and retail mystery programmes. We recommend the mode — or a mixed-mode design — during scoping based on your audience, geography, and timeline.”
View in the company profileHow quickly can we receive a proposal?
“Share your objective, audience, industry, and timeline via the contact form. We typically return a tailored methodology outline within one business day.”
View in the company profile